AMENDED AND RESTATED EMPLOYMENT AGREEMENT Geoffrey CrouseEmployment Agreement • October 19th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledOctober 19th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) effective as of October ___, 2021 (the “Effective Date”), is being entered into by and among Candela Medical, Inc., a Delaware Corporation (the “Company”), Syneron Inc., a Delaware corporation (“Syneron Inc.”) (solely with respect to Section 1(b)), Candela Corporation, a Delaware corporation (“Candela Corporation”) (solely with respect to Section 1(b)) and Geoffrey Crouse (“Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENT Mary TroutEmployment Agreement • October 19th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledOctober 19th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), effective as of October ___, 2021 (the “Effective Date”), is being entered into by and among Candela Medical, Inc., a Delaware Corporation (the “Company”), Syneron Inc., a Delaware corporation (“Syneron Inc.”) (solely with respect to Section 1(b)), [Syneron Candela, a Delaware corporation] (“Syneron Candela”) (solely with respect to Section 1(b)), Candela Corporation, a Delaware corporation (“Candela Corporation”), (solely with respect to Section 1(b)) and Mary Trout (“Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENT Ernest OrticerioEmployment Agreement • October 19th, 2021 • Candela Medical, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
Contract Type FiledOctober 19th, 2021 Company Industry JurisdictionThis AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) effective as of October ___, 2021 (the “Effective Date”), is being entered into by and among Candela Medical, Inc., a Delaware corporation (the “Company”), Candela Corporation, a Delaware corporation (“Candela Corporation”) (solely with respect to Section 1(b)) and Ernest Orticerio (“Executive”).